Paul A Mahon Insider Trades & Stock Holdings

EVP & GENERAL COUNSEL · United Therapeutics Corporation · Latest filing Oct 15, 2026

Paul A Mahon, EVP & GENERAL COUNSEL at United Therapeutics Corporation has 1 Form 4 trade on file since Oct 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($4.52M), net -$4.52M. Latest filing: disposed of 8.30K shares of $UTHR on Oct 15, 2026 at $544.30.

Trades on file

1

Open-market bought

$0

Open-market sold

$4.52M

Net open-market

-$4.52M

Shares held ($UTHR)

45.17K

Latest filing

Oct 15, 2026

Shares held by Paul A Mahon

• $UTHR45.17K sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Paul A Mahon

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 15, 2026	$UTHR	Sell (Open-market sale) 10b5-1	8.30K	$544.30	$4.52M	45.17K	-15.52%				EVP & GENERAL COUNSEL	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Paul A Mahon traded

• $UTHR

Frequently asked questions

Has Paul A Mahon been buying or selling stock?

Paul A Mahon has 0 open-market purchases and 1 open-market sale on file, net -$4.52M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Paul A Mahon's latest insider trade?

disposed of 8.30K shares of $UTHR on Oct 15, 2026 at $544.30.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.